| Literature DB >> 26903613 |
Steven J Hoffman, G Emmanuel Guindon, John N Lavis, Harkanwal Randhawa, Francisco Becerra-Posada, Masoumeh Dejman, Katayoun Falahat, Hossein Malek-Afzali, Parasurama Ramachandran, Guang Shi, C A K Yesudian.
Abstract
Research evidence continues to reveal findings important for health professionals' clinical practices, yet it is not consistently disseminated to those who can use it. The resulting deficits in knowledge and service provision may be especially pronounced in low- and middle-income countries that have greater resource constraints. Tuberculosis treatment is an important area for assessing professionals' knowledge and practices because of the effectiveness of existing treatments and recognized gaps in professionals' knowledge about treatment. This study surveyed 384 health professionals in China, India, Iran, and Mexico on their knowledge and practices related to tuberculosis treatment. Few respondents correctly answered all five knowledge questions (12%) or self-reported performing all five recommended clinical practices "often or very often" (3%). Factors associated with higher knowledge scores included clinical specialization and working with researchers. Factors associated with better practices included training in the care of tuberculosis patients, being based in a hospital, trusting systematic reviews of randomized controlled double-blind trials, and reading summaries of articles, reports, and reviews. This study highlights several strategies that may prove effective in improving health professionals' knowledge and practices related to tuberculosis treatment. Facilitating interactions with researchers and training in acquiring systematic reviews may be especially helpful. © The American Society of Tropical Medicine and Hygiene.Entities:
Mesh:
Year: 2016 PMID: 26903613 PMCID: PMC4856627 DOI: 10.4269/ajtmh.15-0538
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Country profiles in 2005
| China | India | Iran | Mexico | Source | |
|---|---|---|---|---|---|
| Population (in millions) | 1,323 | 1,103 | 70 | 107 | |
| GDP per capita (in PPP international dollar) | 6771 | 3,412 | 8,018 | 10,626 | |
| Per capita total expenditure on health (in PPP international dollar) | 277 | 91 | 604 | 655 | |
| Per capita government expenditure on health (in PPP international dollar) | 105 | 16 | 288 | 304 | |
| Life expectancy at birth for males/females (in years) | 71/74 | 62/65 | 68/71 | 72/77 | |
| Children under-five mortality rate (per 1,000 live births) | 27 | 56 | 36 | 27 | |
| Prevalence of active tuberculosis (per 100,000 population) | 208 | 299 | 30 | 27 | |
| Personal computers per population (%, 2004) | 4 | 3 | 11 | 11 | |
| Internet users per population (%, 2004) | 7 | 1 | 9 | 13 |
Data are for 2005 unless otherwise indicated; PPP = purchasing power parity.
Descriptive statistics on health professionals' individual characteristics, working context, and views about and use of research evidence
| Factor | All ( | China ( | India ( | Iran ( | Mexico ( |
|---|---|---|---|---|---|
| Individual characteristics | |||||
| Age, mean (years) | 39.8 | 37.2 | 43.2 | 34.7 | 48.1 |
| Sex, male | 65.0 | 82.8 | 37.4 | 71.3 | 65.0 |
| Type of health professional | |||||
| General practitioner | 80.8 | 72.4 | 91.8 | 87.0 | 68.3 |
| Specialist physician | 9.7 | 7.8 | 1.0 | 13.0 | 21.7 |
| Nurse | 1.3 | 0.9 | 4.1 | 0 | 0 |
| Health worker | 6.3 | 19.0 | 2.1 | 0 | 0 |
| Other | 1.8 | 0 | 1.0 | 0 | 10.0 |
| Allocation of time (% of time) | |||||
| Clinical practice | 63.3 | 65.5 | 72.7 | 51.0 | 65.0 |
| Research | 4.6 | 6.3 | 0 | 3.2 | 11.3 |
| Teaching | 10.1 | 3.9 | 7.2 | 18.5 | 12.2 |
| Administration | 16.5 | 12.2 | 20.6 | 22.2 | 7.5 |
| Master's or doctorate degree | 4.2 | 1.7 | 1.0 | 2.8 | 16.7 |
| Training since completed last degree | |||||
| Acquiring systematic reviews through the Cochrane Library | 3.0 | 0 | 0 | 2.9 | 15.7 |
| Critically appraising systematic reviews | 5.9 | 7.0 | 1.1 | 2.9 | 17.6 |
| Care of patients with tuberculosis | 78.9 | 91.4 | 96.7 | 61.9 | 55.4 |
| Easy access to personal computer with CD ROM (vs. less easy, not easy, no access, or not sure) | 21.7 | 21.7 | 1.1 | 26.9 | 50.0 |
| Easy access to Internet (vs. less easy, not easy, no access, or not sure) | 19.7 | 18.3 | 1.1 | 24.1 | 48.9 |
| Able to read and write English well or very well (vs. little or no ability) | 52.3 | 16.4 | 98.0 | 50.9 | 48.3 |
| Practice | |||||
| Operating authority of facility or practice | |||||
| Government | 95.0 | 93.1 | 96.0 | 97.2 | 93.3 |
| Nongovernmental organization | 5.5 | 7.8 | 4.0 | 3.7 | 6.7 |
| For-profit organization | 2.6 | 0 | 0 | 9.3 | 0 |
| Type of facility or practice | |||||
| Solo or individual practice | 15.2 | 3.4 | 23.2 | 13.0 | 28.8 |
| Group practice | 4.2 | 1.7 | 0 | 5.6 | 13.6 |
| Hospital | 24.1 | 38.8 | 14.1 | 18.5 | 22.0 |
| Community health center | 55.2 | 9.5 | 80.8 | 81.5 | 54.2 |
| Location of facility or practice | |||||
| Urban | 49.6 | 10.3 | 96.0 | 29.9 | 83.3 |
| Rural | 36.3 | 81.0 | 2.0 | 39.3 | 1.7 |
| Mixed | 14.1 | 8.6 | 2.0 | 30.8 | 15.0 |
| Facility had anti-tuberculosis drugs available | 75.9 | 29.3 | 100.0 | 95.4 | 91.5 |
| Views and activities related to improving clinical practice | |||||
| Research performed in their own country is of above average or excellent quality | 55.7 | 77.6 | 37.0 | 37.4 | 75.0 |
| Trust somewhat or completely a systematic review of randomized controlled double-blind trials | 52.5 | 37.9 | 54.1 | 54.2 | 75.9 |
| Working with researchers or research groups to improve clinical practice or the quality of working life | 24.1 | 42.2 | 6.3 | 16.8 | 31.0 |
| Higher quality of available research is important or very important to improve their work | 77.5 | 76.7 | 59.6 | 85.2 | 94.9 |
| Used or read particular sources of evidence | |||||
| Clinical practice guidelines, protocols or decision-support tools | 54.7 | 76.5 | 48.0 | 26.2 | 74.5 |
| Cochrane Library | 5.5 | 0.9 | 0 | 5.6 | 26.8 |
| Scientific journals from high-income countries | 17.9 | 0.9 | 4.5 | 23.1 | 64.0 |
| Scientific journals from own country | 58.3 | 67.8 | 41.6 | 47.6 | 81.8 |
| Summaries of articles, reports, and reviews from public and not-for-profit health organizations | 55.8 | 46.1 | 54.4 | 59.8 | 71.2 |
Note that because of variations among sampling frames and a limited sample size, these results cannot, and should not, be compared across countries.
May not add to 100% because health professional may practice in more than one setting.
May not add to 100% because the allocation of time reported by a small number of respondents did not add to 100%.
Questions assessing health professionals' knowledge about treating tuberculosis
| Question (multiple choice) | Answer (A, B, C, D, E, F) | All ( | China ( | India ( | Iran ( | Mexico ( |
|---|---|---|---|---|---|---|
| 1) What factors accelerate the progression from tuberculosis infection to disease? | (A) Malnutrition [T] | 95.3% | 91.4% | 96.0% | 98.1% | 96.7% |
| (B) HIV infection [T] | 95.6% | 91.4% | 93.0% | 100.0% | 100.0% | |
| (C) Diabetes [T] | 63.5% | 63.8% | 35.0% | 76.9% | 86.7% | |
| (D) Long-term treatment with corticosteroids or immunosuppressive medications [T] | 80.7% | 96.7% | 34.0% | 99.1% | 95.0% | |
| (E) Bacillus Calmette-Guerin (BCG) vaccination [F] | 26.6% | 69.8% | 3.0% | 6.5% | 18.3% | |
| (★) Correctly answered A, B, C, D, and not E | 43.5% (167/384) | 19.8% (23/116) | 27.0% (27/100) | 71.3% (77/108) | 66.7% (40/60) | |
| 2) All of the following are first line therapy for TB except: | (A) Isoniazid [F] | 9.4% | 0% | 0% | 15.7% | 31.7% |
| (B) Rifampin [F] | 8.9% | 0% | 0% | 15.7% | 28.3% | |
| (C) Streptomycin [F] | 10.4% | 1.7% | 2.0% | 16.7% | 30.0% | |
| (D) Cycloserine [T] | 89.3% | 99.1% | 99.0% | 82.4% | 66.7% | |
| (E) Ethambutol [F] | 9.6% | 0% | 0% | 16.7% | 31.7% | |
| (★) Correctly answered D and not A, B, C, E | 87.2% (335/384) | 98.3% (114/116) | 98.0% (98/100) | 78.7% (85/108) | 63.3% (38/60) | |
| 3) The major side effect of isoniazid therapy is:* | (A) Gastritis [F] | 21.3% | 12.9% | 49.0% | 1.9% | 27.8% |
| (B) Hepatitis [T] | 66.5% | 87.9% | 25.5% | 88.9% | 50.0% | |
| (C) Diarrhea [F] | 4.5% | 7.8% | 4.1% | 0.9% | 5.6% | |
| (D) Tubular necrosis [F] | 12.0% | 6.9% | 31.6% | 0.9% | 9.3% | |
| (E) Optic neuritis [F] | 23.4% | 52.6% | 7.1% | 9.3% | 18.5% | |
| (★) Correctly answered B and not A, C, D, E | 45.4% (171/376) | 34.5% (40/116) | 13.3% (13/98) | 87.0% (94/108) | 44.4% (24/54) | |
| 4) Which one of the following is the best indicator of a patient not being infectious?† | (A) Patient has received at least 2 weeks of TB medications [F] | 12.8% | 2.6% | 2.0% | 37.7% | 6.7% |
| (B) Patient has no cough [F] | 4.7% | 4.3% | 1.0% | 7.5% | 6.7% | |
| (C) Patient has three negative acid-fast bacilli (AFB) sputum smears on three consecutive days [T] | 83.8% | 94.8% | 97.0% | 55.7% | 90.0% | |
| (★) Correctly answered C and not A, B | 82.7% (316/382) | 93.1% (108/116) | 97.0% (97/100) | 54.7% (58/106) | 88.3% (53/60) | |
| 5) The minimum duration of therapy for culture-proven active TB is: | (A) 2 weeks [F] | 0.3% | 0.9% | 0% | 0% | 0% |
| (B) 6 weeks [F] | 3.7% | 6.9% | 1.0% | 2.8% | 3.4% | |
| (C) 2 months [F] | 2.9% | 0% | 1.0% | 3.7% | 10.2% | |
| (D) 6 months [T] | 87.7% | 94.8% | 80.6% | 92.6% | 76.3% | |
| (E) 9 months [F] | 4.5% | 0% | 16.3% | 0% | 1.7% | |
| (F) 12 months [F] | 2.1% | 0% | 1.0% | 0.9% | 10.2% | |
| (★) Correctly answered D and not A, B, C, E, F | 86.9% (331/381) | 92.2% (107/116) | 80.6% (79/98) | 92.6% (100/108) | 76.3%(45/59) | |
| All five questions | Answered correctly | 11.7% (45/384) | 5.2% (6/116) | 5.0% (5/100) | 19.4% (21/108) | 21.7% (13/60) |
[T] = true, [F] = false. Data show the percentage and fraction of respondents who correctly answered each question. Note that because of variations among sampling frames and a limited sample size, these results cannot, and should not, be compared across countries.
In Chinese, the words “is” and “are” are the same. Chinese health professionals, therefore, were disadvantaged in answering this question as they were not told that there is only one major side effect of isoniazid therapy (as indicated by the word “is” in English as compared with “are”). This language difference likely explains why many Chinese health professionals circled more than one answer for this question, while health professionals from other countries consistently circled only one answer. The proportion reported in this study, therefore, shows the number of Chinese professionals who circled the correct answer, regardless of whether incorrect answers were also circled.
Practice guidelines in Iran are different from the WHO guidelines that were used as correct answers for this test question.
Questions assessing health professionals' practices relating to treating tuberculosis
| Question (multiple choice) | Answer (frequency) | All ( | China ( | India ( | Iran ( | Mexico ( |
|---|---|---|---|---|---|---|
| 1) When treating new active tuberculosis patients, how often did the provider prescribe a treatment regimen of 5 months or less? [Contrary to recommended practice] | (A) Never | 72.6% | 89.7% | 65.7% | 81.5% | 35.0% |
| (B) Rarely | 9.7% | 0.9% | 24.2% | 3.7% | 13.3% | |
| (C) Sometimes | 3.9% | 0% | 8.1% | 2.8% | 6.7% | |
| (D) Often | 1.8% | 0% | 1.0% | 0% | 10.0% | |
| (E) Very often | 2.9% | 0% | 1.0% | 1.9% | 15.0% | |
| (F) N/A | 9.1% | 9.5% | 0% | 10.2% | 20.0% | |
| Never or rarely | 82.3% | 90.6% | 89.9% | 85.2% | 48.3% | |
| 2) When treating new active tuberculosis patients, how often did the provider (or someone acting on their behalf) ensure that the treatment was taken for at least 2 months in the presence of a health worker? [Recommended practice] | (A) Never | 5.5% | 9.6% | 0% | 3.7% | 10.0% |
| (B) Rarely | 3.4% | 0% | 0% | 9.3% | 5.0% | |
| (C) Sometimes | 3.9% | 2.6% | 1.0% | 8.3% | 3.3% | |
| (D) Often | 24.5% | 29.6% | 11.0% | 35.2% | 18.3% | |
| (E) Very often | 56.4% | 49.6% | 88.0% | 39.8% | 46.7% | |
| (F) N/A | 6.3% | 8.7% | 0% | 3.7% | 16.7% | |
| Often or very often | 80.9% | 79.2% | 99% | 75% | 65% | |
| 3) Before initiating treatment with new active tuberculosis patients, how often did the provider (or someone acting on their behalf) provide health education on the importance of taking medication regularly? [Recommended practice] | (A) Never | 2.4% | 0.9% | 1.0% | 1.9% | 8.3% |
| (B) Rarely | 1.0% | 0% | 0% | 3.7% | 0% | |
| (C) Sometimes | 3.4% | 2.6% | 0% | 4.6% | 8.3% | |
| (D) Often | 24.0% | 40.9% | 10.0% | 22.2% | 18.3% | |
| (E) Very often | 64.2% | 49.6% | 89.0% | 64.8% | 50.0% | |
| (F) N/A | 5.0% | 6.1% | 0% | 2.8% | 15.0% | |
| Often or very often | 88.2% | 90.5% | 99% | 87% | 68.3% | |
| 4) When treating new active tuberculosis patients, how often did the provider (or someone acting on their behalf) notify the health authority about the new patients? [Recommended practice] | (A) Never | 4.2% | 3.5% | 0% | 6.5% | 8.3% |
| (B) Rarely | 2.1% | 2.6% | 0% | 2.8% | 3.3% | |
| (C) Sometimes | 2.9% | 4.4% | 0% | 4.6% | 1.7% | |
| (D) Often | 18.0% | 35.7% | 12.0% | 6.5% | 15.0% | |
| (E) Very often | 67.4% | 49.6% | 87.0% | 74.1% | 56.7% | |
| (F) N/A | 5.5% | 4.4% | 1.0% | 5.6% | 15.0% | |
| Often or very often | 85.4% | 85.3% | 99% | 80.6% | 71.7% | |
| 5) When treating HIV-infected individuals, how often did the provider recommend preventive chemotherapy for tuberculosis? [Recommended practice] | (A) Never | 31.1% | 9.5% | 45.0% | 44.9% | 25.0% |
| (B) Rarely | 2.6% | 0% | 4.0% | 1.9% | 6.7% | |
| (C) Sometimes | 2.9% | 1.7% | 4.0% | 1.9% | 5.0% | |
| (D) Often | 6.5% | 1.7% | 13.0% | 2.8% | 11.7% | |
| (E) Very often | 12.0% | 0% | 27.0% | 5.6% | 21.7% | |
| (F) N/A | 44.9% | 87.1% | 7.0% | 43.0% | 30.0% | |
| Often or very often | 18.5% | 1.7% | 40% | 8.4% | 33.4% | |
| All recommended practices | Followed often or very often | 3.1% (12/384) | 0% (0/116) | 7.0% (7/100) | 1.9% (2/108) | 5.0% (3/60) |
Data show the percentage and fraction of respondents who over the previous 12 months engaged in the recommended practices described in the first four questions either often or very often (vs. never, rarely, sometimes, and not applicable) and who never engaged in the non-recommended practice as described in the last question (vs. rarely, sometimes, often, very often, and not applicable). Note that because of variations among sampling frames and a limited sample size, these results cannot, and should not, be compared across countries.
Ordinal logistic models for the factors associated with the log odds of having higher knowledge and better practices
| Factor | Knowledge ( | Practices ( | ||
|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |
| Individual and practice characteristics | ||||
| Age | 1.02 | (0.82, 1.28) | 0.97 | (0.78, 1.21) |
| Age squared | 1.00 | (1.00, 1.00) | 1.00 | (1.00, 1.00) |
| Sex, male | 0.75 | (0.37, 1.56) | 0.84 | (0.53, 1.31) |
| Specialist physician | 2.19 | (0.95, 5.07) | ||
| Time allocated to research | 1.00 | (1.00, 1.01) | 1.00 | (0.97, 1.03) |
| Master's or doctorate degree | 1.16 | (0.48, 2.78) | 0.74 | (0.23, 2.38) |
| Training (since completed last degree) in: | ||||
| Acquiring systematic reviews through the Cochrane Library | 0.82 | (0.44, 1.54) | 1.94 | (0.88, 4.26) |
| Critically appraising systematic reviews | 0.70 | (0.36, 1.35) | 1.37 | (0.51, 3.68) |
| The care of patients with tuberculosis | 1.15 | (0.73, 1.80) | ||
| Easy access to the internet | 1.11 | (0.76, 1.63) | 0.75 | (0.22, 2.62) |
| Able to read and write English well or very well | 0.86 | (0.31, 2.39) | 1.02 | (0.71, 1.47) |
| Working context | ||||
| Based in a facility or practice with an NGO as the operating authority | 0.65 | (0.19, 2.25) | 0.78 | (0.36, 1.71) |
| Located in an urban setting | 0.93 | (0.45, 1.90) | 1.36 | (0.91, 2.01) |
| Based in a hospital | 0.73 | (0.42, 1.26) | ||
| Facility had anti-tuberculosis drugs available | 0.67 | (0.41, 1.10) | 1.10 | (0.26, 4.70) |
| Views and activities related to improving clinical practice | ||||
| Research performed in their own country is of above average or excellent quality | 0.67 | (0.26, 1.70) | 0.98 | (0.76, 1.25) |
| Trust somewhat or completely a systematic review of randomized controlled double-blind trials | 0.95 | (0.58, 1.56) | ||
| Working with researchers or research groups to improve clinical practice or the quality of working life | 1.08 | (0.82, 1.42) | ||
| Higher quality of available research is important or very important to improve their work | 0.62 | (0.37, 1.04) | 1.26 | (0.89, 1.78) |
| Used or read particular sources of evidence | ||||
| Clinical practice guidelines, protocols or decision-support tools | 0.93 | (0.50, 1.72) | 1.37 | (0.59, 3.16) |
| Cochrane Library | 0.81 | (0.16, 4.11) | 0.79 | (0.24, 2.54) |
| Scientific journals from high-income countries | 0.58 | (0.21, 1.63) | 0.60 | (0.18, 2.01) |
| Scientific journals from own country | 1.14 | (0.65, 1.98) | 1.46 | (0.80, 2.64) |
| Summaries of articles, reports, and reviews from public and not-for-profit health organizations | 0.82 | (0.59, 1.15) | 1.42 | |
| Thresholds | ||||
| k1 | −1.59 | (−5.81, 2.62) | −0.27 | (−4.32, 3.77) |
| k2 | −0.36 | (−4.66, 3.95) | 1.11 | (−2.95, 5.17) |
| k3 | 0.28 | (−3.95, 4.50) | 2.24 | (−1.89, 6.38) |
| k4 | 1.72 | (−2.51, 5.95) | 3.55 | (0.00, 7.09) |
CI = confidence interval; NGO = nongovernmental organization; OR = odds ratio. Standard errors adjusted for four clusters (i.e., countries). All regression models include country dummies (China is the reference country). Bolded entries were statistically significant factors in the models.
Entered in regression models as continuous variables measured in years.
Entered in regression models as continuous variable measured in percent of time (0–100).